
Odospi S 1000mg/1000mg Injection
Marketer
Auspi Medicaments
Salt Composition
Cefoperazone (1000mg) + Sulbactam (1000mg)
Overview Odospi S 1000mg/1000mg Injection
Combiflox 1000mg/1000mg Injection, a dual-action formulation, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thereby controlling infection spread. Administration must be strictly under a doctor's guidance; adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement, as premature cessation may compromise efficacy. Common reactions include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical attention. Seek urgent medical care for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are vital for optimal recovery. Your physician may order blood tests and other diagnostic procedures to monitor treatment effectiveness.
Uses of Odospi S 1000mg/1000mg Injection
Combating Bacterial Infections
Major Benefits of Odospi S 1000mg/1000mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Odospi S 1000mg/1000mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Odospi S 1000mg/1000mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Odospi S 1000mg/1000mg Injection works:
Odospi S 1000mg/1000mg injectable solution unites Cefoperazone, a broad-spectrum antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to survive. Sulbactam complements this by counteracting bacterial resistance mechanisms, thereby optimizing Cefoperazone's antimicrobial efficacy.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Odospi S 1000mg/1000mg Injection treatment can lead to adverse effects including facial redness, rapid pulse, vomiting, dehydration, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Odospi S (1000mg/1000mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nonetheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Odospi S (1000mg/1000mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal transfer of the drug into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Odospi S 1000mg/1000mg Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Odospi S 1000mg/1000mg Injection to individuals with renal impairment. Seek medical advice.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Odospi S 1000mg/1000mg Injection to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Odospi S 1000mg/1000mg Injection :
Should you forget a scheduled dose of Odospi S 1000mg/1000mg Injection, seek medical advice.
Facts to Know About Odospi S 1000mg/1000mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
